Previous 10 | Next 10 |
LAWRENCEVILLE, NJ, March 31, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional investors for the purchase and sale of 11,538,462 shares of it...
RLX Technology (RLX) -40%.Takung Art (TKAT) -16%.Turkcell Iletisim Hizmetleri (TKC) -14%Farmmi (FAMI) -13% on proposed underwritten public offering of ordinary shares.Yunji (YJ) -11% on Q4 earnings release.SenesTech (SNES) -10%.Banco Bilbao Vizcaya Argentaria (BBVA) -6%.Or...
Celsion Corporation (CLSN) Q4 2020 Earnings Conference Call March 19, 2021 11:00 AM ET Company Participants Kim Golodetz - Investor Relations Michael Tardugno - Chairman, CEO and President Jeff Church - Chief Financial Officer Khursheed Anwer - Chief Science Officer Nicholas Borys - Chief Med...
Despite reporting EPS this morning for 2020 that beat analyst expectations and revenue that was in-line, Celsion (CLSN) shares are struggling this afternoon.The company says that its phase 1/2 OVATION 2 study for its ovarian cancer immunotherapy GEN-1 is one-third complete with enrollmen...
Celsion (CLSN): FY GAAP EPS of -$0.67 beats by $0.06.Revenue of $0.5M in-line (flat Y/Y).Shares +1.32% PM.Press Release For further details see: Celsion EPS beats by $0.06, revenue in-line
Entered 2021 with a Focus on Cancer Immunotherapy and Next-Generation Infectious Vaccines and a Strong Balance Sheet Conference Call Begins at 11:00 a.m. Eastern Time Today LAWRENCEVILLE, N.J., March 19, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) ...
LAWRENCEVILLE, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announced today that the Company will host a conference call at 11:00 a.m. EDT on Friday...
Evofem Biosciences EVFM -25% on Q4 earnings release.Super League Gaming (SLGG) -19%.GSX Techedu GSX -15% on Q4 earnings release.T2 Biosystems TTOO -10% on Q4 earnings release.Senseonics Holdings SENS -9% on Q4 earnings release.Aerpio Pharmaceuticals ARP...
LAWRENCEVILLE, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that a poster on the Company’s Phase I/II OVATION 2 Study...
Today, we revisit biotech concern Celsion Corporation for the first time in over a half-decade. The stock still trades right near the $2 level just like it did when we last took a look at this small-cap name in 2015. News flow in 2021 has picked up, so it's time to circle back on ...
News, Short Squeeze, Breakout and More Instantly...
New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines LAWRENCEVILLE, N.J., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage drug development company, today announced ...
110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Chemotherapy Alone LAWRENCEVILLE, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage company focused on DNA-ba...
LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 24 th An...